4D Molecular Therapeutics, Inc. (FDMT): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

57.93M
Year ended 2025-12-31
+21.4%
3-year compound annual growth
2021-12-31: 27.73M2022-12-31: 32.35M2023-12-31: 39.13M2024-12-31: 53.94M2025-12-31: 57.93M57.93M
2021-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3157.93M+7.4%2026-03-18, From 2025-01-01
2024-12-3153.94M+37.9%2026-03-18, From 2024-01-01
2023-12-3139.13M+21.0%2025-02-28, From 2023-01-01
2022-12-3132.35M+16.7%2024-02-29, From 2022-01-01
2021-12-3127.73Mn/a2023-03-15, From 2021-01-01